IQVIA's U.S. Thought Leadership & Innovation (U.S. TL&I) is a collaborative network of IQVIA experts delivering market intelligence at the intersection of policy, economics, market access, real-world evidence, and analytics. It helps healthcare and life sciences organizations turn market complexity into clearer, evidence-driven decisions through insights and publications in the U.S. TL&I Insights Library, organized around five pillars: Finding Life Sciences Success in Modern Markets, Therapeutic Area Deep Dives, State of the Industry, Modern Analytics & Next Generation Insights, and What's New & What's Next.

Five forces are reshaping the U.S. market: policy reform, economic pressure, scientific innovation, evolving stakeholder expectations, and advances in analytics and technology. Together they challenge traditional approaches to launch, market access, and commercialization, forcing organizations to adapt continuously to stay competitive.

Strong modern launch readiness now depends on far more than regulatory approval. It requires understanding patient and provider needs, anticipating access and reimbursement hurdles, mapping competitive dynamics, and aligning commercial strategy to real market conditions. Companies that plan across all four dimensions launch faster and defend value better.

AI is helping life sciences organizations analyze data faster, surface actionable insights, and accelerate decisions across R&D, commercial strategy, and operations. From transforming brand strategy through predictive analytics to addressing the barriers that have slowed broader adoption across the industry, AI is rapidly reshaping how organizations operate. Its long-term impact will depend on pairing innovation with trust, governance, and responsible implementation.

Patients are shifting from a provider-driven model to actively researching options, seeking treatment, and influencing their own care, a move toward patient consumerism. Life sciences companies must respond with accessible, relevant information that supports informed decisions across the treatment journey.

Commercial success today depends on far more than clinical innovation. Rising policy complexity, margin pressure, and global market dynamics are reshaping how products are evaluated, adopted, and used, changing commercialization models and how organizations approach access, value, and differentiation.

Advanced analytics and real-world evidence turn complex data into clearer decisions, illuminating patient behavior, access barriers, treatment utilization, market dynamics, and the impact of policy change. Used across the lifecycle, they move organizations from data collection to confident, evidence-based action.

Insight Express is a short-form video series in which IQVIA experts deliver rapid, data-driven insights into the dynamics shaping innovation, access, competition, and commercial success. Across a handful of concise episodes, it gives readers a practical foundation for understanding the trends driving healthcare's future.

Leaders should watch specialty therapeutics, evolving access and affordability models, healthcare economics, advanced analytics, and shifting commercialization strategy. These dynamics will most determine market success and outlook over the next several years.

We offer the most robust view of U.S. pharmaceutical market performance, combining market access insights, healthcare policy analysis, stakeholder behavior, therapeutic trends, and commercial analytics to help pharmaceutical and biotech companies optimize commercialization and launch success.

Success in the obesity market requires a clear understanding of rapidly evolving patient, provider, payer, and competitive dynamics. With one of the industry’s most comprehensive views of the obesity ecosystem, including a video blog series, spanning GLP-1 adoption, coverage trends, emerging indications, and 200+ therapies in development, we help life science and healthcare organizations to anticipate change, uncover opportunities, and confidently guide commercial strategy.